Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,922 | -923 | -17,082 | -16,382 | -15,722 |
| Depreciation Amortization | 854 | 407 | 1,142 | 782 | 418 |
| Accounts receivable | 3 | -83 | 32 | 5 | 7 |
| Accounts payable and accrued liabilities | 35 | 36 | -229 | -213 | -230 |
| Other Working Capital | 114 | -43 | -216 | -215 | -150 |
| Other Operating Activity | 571 | 410 | 15,615 | 15,468 | 15,361 |
| Operating Cash Flow | $-346 | $-196 | $-739 | $-556 | $-315 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -7 | -16 | N/A | N/A |
| Investing Cash Flow | $-7 | $-7 | $-16 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 350 | 250 | 1,402 | 1,252 | 1,002 |
| Debt Repayment | -23 | -12 | -46 | -34 | -23 |
| Common Stock Issued | 32 | N/A | 25 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -602 | -602 | -602 |
| Other Financing Activity | 0 | 0 | -3 | -2 | -3 |
| Financing Cash Flow | $359 | $238 | $777 | $614 | $375 |
| Beginning Cash Position | 43 | 43 | 20 | 20 | 20 |
| End Cash Position | 49 | 78 | 43 | 78 | 80 |
| Net Cash Flow | $7 | $35 | $23 | $58 | $60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -346 | -196 | -739 | -556 | -315 |
| Capital Expenditure | -7 | -7 | -16 | N/A | N/A |
| Free Cash Flow | -353 | -203 | -755 | -556 | -315 |